Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Distally expanding cervical facet implant to improve neck alignment and widen nerve openings

Official title: Improving Cervical Spine Alignment and Intervertebral Foramen Expansion Using a Novel Distally Expanding Cervical Facet Implant (CeLFI) for Cervical Degenerative Disease

Run by King Saud University · NCT07142174 · Data updated 2026-11-12

This study tests a new distally expanding cervical facet implant to widen nerve openings and maintain alignment in adults having posterior surgery for cervical degenerative disease.

More Degenerative Disc Disease trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorKing Saud University
Academic / other
Locations1 site (Riyadh)
StatusRecruiting
StartedDecember 1, 2024
Main results expectedDecember 2026
Study endsJune 2027
Registry record updatedAugust 26, 2025
Trial IDNCT07142174 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 undergoing posterior cervical spine surgery for degenerative radiculopathy or myelopathy with mobile levels showing foraminal stenosis or spondylolisthesis are ideal candidates.

Probably not a fit

Patients with non-degenerative cervical conditions (infection, tumor, trauma), severe instability, or those not receiving a posterior approach are unlikely to benefit from this device.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective clinical study will insert a novel distally expanding cervical facet implant (CeLFI) via a posterior approach to provide anterior distraction of the facet joint space and thereby enlarge the intervertebral foramina. The device has prior biomechanical and cadaver validation and will be placed at levels that are mobile on flexion-extension x-rays and show foraminal stenosis or spondylolisthesis. Twenty adult patients undergoing posterior cervical surgery for radiculopathy or myelopathy will be enrolled with informed consent and followed with clinical exams and imaging to document alignment, foraminal size, neurologic status, and device-related safety. Outcomes will compare pre- and postoperative radiographs and clinical measures to determine whether the implant achieves indirect nerve decompression while preserving stability.

Why it matters

Potential benefit: If successful, the implant could relieve nerve compression while preserving cervical alignment and stability, potentially avoiding more invasive anterior procedures.

How similar studies have gone: Similar posterior facet spacer approaches have shown biomechanical and early clinical promise, but this specific distally expanding CeLFI device is novel and is being tested in humans.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \> 18
* Signed Informed Consent
* Patients undergoing posterior cervical Spine surgery for CDD (for radiculopathy or myelopathy)

Exclusion Criteria:

* Non-degenerative cervical spine pathologies, including infection, tumor, or trauma.

Where it's running

  • King Saud University Medical City
    Riyadh, Saudi Arabia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.